Cancer BiologybioRxivPreprint
Protein arginine-methyltransferase 1 (PRMT1): a new pharmacological target in cholangiocarcinoma
Emiliana Valbuena-Goiricelaya, Jasmin Elurbide, Maria Ujue Latasa…·Matias Antonio Avila
This study identifies PRMT1 as a critical driver of cholangiocarcinoma growth and immune evasion, showing its inhibition enhances antitumor immunity and synergizes with immunotherapy.
DOI 10.64898/2026.05.29.728163